2019
DOI: 10.1016/j.bjps.2019.07.021
|View full text |Cite
|
Sign up to set email alerts
|

Dermal regenerative matrix use in burn patients: A systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
27
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(32 citation statements)
references
References 69 publications
0
27
0
1
Order By: Relevance
“…While the primary goal of the rapid and permanent coverage of burn wounds is to protect from infections, these regenerative cell-based therapies have occasionally been a ground for the initiation of infections in the clinic. In fact, infection of the DRTs and the graft site is a major early complication associated with this type of treatment [6][7][8].…”
Section: Introductionmentioning
confidence: 99%
“…While the primary goal of the rapid and permanent coverage of burn wounds is to protect from infections, these regenerative cell-based therapies have occasionally been a ground for the initiation of infections in the clinic. In fact, infection of the DRTs and the graft site is a major early complication associated with this type of treatment [6][7][8].…”
Section: Introductionmentioning
confidence: 99%
“…The dermal matrix allows for migration of fibroblasts and macrophages and becomes vascularized and incorporated into the body, and the silastic epidermis is removed and autografted 3 weeks after application. Integra carries the advantage of easy storage and decreased contracture compared to autograft only [104,105], and of being able to survive on small exposed areas of bone or tendon, on which autograft alone does not survive. Disadvantages include infections and its high cost [17,105].…”
Section: Skin Substitutesmentioning
confidence: 99%
“…Integra carries the advantage of easy storage and decreased contracture compared to autograft only [104,105], and of being able to survive on small exposed areas of bone or tendon, on which autograft alone does not survive. Disadvantages include infections and its high cost [17,105]. Biodegradable Temporizing Matrix, or BTM ® , is a synthetic polyurethane dermal substitute developed in 2012 by Greenwood that incorporates into the body through ingrowth of blood vessels and fibroblast infiltration [106,107].…”
Section: Skin Substitutesmentioning
confidence: 99%
“…However, stable healing cannot be achieved in all patients using these techniques. Although some progress has been made using different templates and matrices [ 10 ], these techniques are still dependent on a minimum degree of perfusion of the wound bed, which is not the situation following high voltage electrical trauma, and are limited in the thickness and quality of the soft tissue they provide [ 11 ].…”
Section: Indicationmentioning
confidence: 99%